Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

650 nm red light helps hair grow and prevents hair loss by affecting certain genes and biological processes.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Higher hair follicle density leads to more wool in rabbits, influenced by specific genes and lncRNAs.

New engineering methods show promise for regenerating hair follicles using stem cells and advanced technologies.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Tofacitinib is an effective and safe treatment for alopecia areata.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Higher RBP4 levels are linked to severe alopecia areata, but genetic variant rs3758539 doesn't affect baricitinib response.

These new skin treatments are safer and more effective with minimal side effects.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Clonally expanded CD8+ T cells cause alopecia areata.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

Standardizing light therapy methods could improve spinal cord injury treatment.

Metal nanoparticles show promise for treating hair loss but need more research to ensure safety.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Organoids and hair-on-chip technologies show promise for hair regeneration but face clinical challenges.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.